Advances in imaging for diagnosis and management of cardiac sarcoidosis
Author(s) -
Niti R. Aggarwal,
David Snipelisky,
Phillip M. Young,
B.J. Gersh,
Leslie T. Cooper,
Panithaya Chareonthaitawee
Publication year - 2015
Publication title -
european heart journal - cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.576
H-Index - 92
eISSN - 2047-2412
pISSN - 2047-2404
DOI - 10.1093/ehjci/jev142
Subject(s) - sarcoidosis , cardiac sarcoidosis , medicine , endomyocardial biopsy , gold standard (test) , cardiomyopathy , modalities , cardiology , intensive care medicine , radiology , biopsy , heart failure , social science , sociology
Sarcoidosis is a multisystem granulomatous disorder with a high prevalence of cardiac involvement. Cardiac sarcoidosis (CS) may be life threatening due to end-stage cardiomyopathy and sudden cardiac death. The frequent absence of specific symptoms and lack of a diagnostic 'gold standard' pose challenges in the diagnosis of CS. Endomyocardial biopsy, although specific, has an unacceptably low sensitivity. Non-invasive cardiac imaging has a huge role in the assessment of patients with known or suspected CS. This comprehensive review compares the diagnostic accuracy, along with advantages and disadvantages, of established and emerging imaging modalities for CS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom